|
US11120889B2
(en)
*
|
2012-05-09 |
2021-09-14 |
Georgia Tech Research Corporation |
Method for synthesizing a nuclease with reduced off-site cleavage
|
|
CN111218447B
(zh)
|
2013-11-07 |
2024-10-11 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
WO2018013558A1
(en)
*
|
2016-07-12 |
2018-01-18 |
Life Technologies Corporation |
Compositions and methods for detecting nucleic acid regions
|
|
WO2019040650A1
(en)
|
2017-08-23 |
2019-02-28 |
The General Hospital Corporation |
GENETICALLY MODIFIED CRISPR-CAS9 NUCLEASES HAVING MODIFIED PAM SPECIFICITY
|
|
CN107723358B
(zh)
*
|
2017-10-26 |
2021-03-19 |
国家卫生健康委科学技术研究所 |
苯丙酮尿症检测试剂盒
|
|
CA3104989A1
(en)
*
|
2018-03-27 |
2019-10-03 |
G+Flas Life Sciences |
Sequence-specific in vivo cell targeting
|
|
US20210261957A1
(en)
*
|
2018-07-10 |
2021-08-26 |
Alia Therapeutics S.R.L. |
Vesicles for traceless delivery of guide rna molecules and/or guide rna molecule/rna-guided nuclease complex(es) and a production method thereof
|
|
AU2019327449B2
(en)
|
2018-08-28 |
2026-04-09 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
CN113272428A
(zh)
*
|
2018-10-18 |
2021-08-17 |
英特利亚治疗股份有限公司 |
核酸构建体和使用方法
|
|
WO2020191241A1
(en)
*
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
CA3147875A1
(en)
|
2019-07-19 |
2021-01-28 |
Flagship Pioneering Innovations Vi, Llc |
Recombinase compositions and methods of use
|
|
EP4034659A4
(en)
|
2019-09-27 |
2024-10-16 |
The Broad Institute, Inc. |
PROGRAMMABLE POLYNUCLEOTIDE EDITORS FOR AMPLIFIED HOMOLOGOUS RECOMBINATION
|
|
EP4061940A4
(en)
|
2019-11-22 |
2024-10-23 |
Flagship Pioneering Innovations VI, LLC |
RECOMBINASE COMPOSITIONS AND METHODS OF USE
|
|
WO2021138469A1
(en)
|
2019-12-30 |
2021-07-08 |
The Broad Institute, Inc. |
Genome editing using reverse transcriptase enabled and fully active crispr complexes
|
|
BR112022017715A2
(pt)
|
2020-03-04 |
2022-11-16 |
Flagship Pioneering Innovations Vi Llc |
Métodos e composições para modular um genoma
|
|
AU2021232005A1
(en)
|
2020-03-04 |
2022-09-29 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
US20230348939A1
(en)
|
2020-03-04 |
2023-11-02 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
IL296095A
(en)
|
2020-03-04 |
2022-11-01 |
Flagship Pioneering Innovations Vi Llc |
Improved methods and compositions for genome modulation
|
|
BR112022017735A2
(pt)
|
2020-03-05 |
2022-11-29 |
Flagship Pioneering Innovations Vi Llc |
Métodos e composições de supressão de defesa de hospedeiro para modular um genoma
|
|
CA3177481A1
(en)
|
2020-05-08 |
2021-11-11 |
David R. Liu |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
TW202208632A
(zh)
*
|
2020-05-27 |
2022-03-01 |
美商同源醫藥公司 |
用於恢復pah基因功能的腺相關病毒組成物及其使用方法
|
|
WO2021248102A1
(en)
|
2020-06-05 |
2021-12-09 |
Flagship Pioneering Innovations Vi, Llc |
Template guide rna molecules
|
|
AU2022206476A1
(en)
|
2021-01-11 |
2023-07-20 |
President And Fellows Of Harvard College |
Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
|
|
US20240132916A1
(en)
|
2021-02-09 |
2024-04-25 |
The Broad Institute, Inc. |
Nuclease-guided non-ltr retrotransposons and uses thereof
|
|
WO2022183210A1
(en)
|
2021-02-26 |
2022-09-01 |
Flagship Pioneering Innovations Vi, Llc |
Tissue-specific methods and compositions for modulating a genome
|
|
AU2022240747A1
(en)
|
2021-03-19 |
2023-10-05 |
Flagship Pioneering Innovations Vi, Llc |
Ltr transposon compositions and methods
|
|
EP4314257A4
(en)
|
2021-04-01 |
2025-07-09 |
Prime Medicine Inc |
METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES
|
|
EP4347859A4
(en)
|
2021-05-26 |
2025-07-02 |
Flagship Pioneering Innovations Vi Llc |
INTEGRASE COMPOSITIONS AND METHODS
|
|
EP4352230A4
(en)
|
2021-06-03 |
2025-06-11 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treating Wilson's disease
|
|
WO2023283092A1
(en)
|
2021-07-06 |
2023-01-12 |
Prime Medicine, Inc. |
Compositions and methods for efficient genome editing
|
|
WO2023004439A2
(en)
|
2021-07-23 |
2023-01-26 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of chronic granulomatous disease
|
|
WO2023015318A2
(en)
|
2021-08-05 |
2023-02-09 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of cystic fibrosis
|
|
AU2022325166A1
(en)
|
2021-08-06 |
2024-02-08 |
President And Fellows Of Harvard College |
Improved prime editors and methods of use
|
|
CA3231712A1
(en)
|
2021-09-08 |
2023-03-16 |
Flagship Pioneering Innovations Vi, Llc |
Pah-modulating compositions and methods
|
|
KR20260037664A
(ko)
|
2021-09-08 |
2026-03-18 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
게놈을 조절하기 위한 방법 및 조성물
|
|
MX2024002930A
(es)
|
2021-09-08 |
2024-05-29 |
Flagship Pioneering Innovations Vi Llc |
Metodos y composiciones para modular un genoma.
|
|
WO2023039447A2
(en)
|
2021-09-08 |
2023-03-16 |
Flagship Pioneering Innovations Vi, Llc |
Serpina-modulating compositions and methods
|
|
EP4399307A4
(en)
|
2021-09-08 |
2026-01-21 |
Flagship Pioneering Innovations Vi Llc |
HBB COMPOSITIONS AND MODULATION METHODS
|
|
CA3235826A1
(en)
|
2021-10-21 |
2023-04-27 |
Wei Hsi Yeh |
Genome editing compositions and methods for treatment of usher syndrome type 3
|
|
US20250011766A1
(en)
|
2021-11-09 |
2025-01-09 |
Prime Medicine, Inc. |
Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis
|
|
US20250319202A1
(en)
|
2021-11-09 |
2025-10-16 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of fuchs endothelial corneal dystrophy
|
|
EP4430189A1
(en)
|
2021-11-11 |
2024-09-18 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of fragile x syndrome
|
|
US20250297248A1
(en)
|
2021-11-24 |
2025-09-25 |
Prime Medicine, Inc. |
Methods and compositions for inhibiting mismatch repair
|
|
AU2022398241A1
(en)
|
2021-11-24 |
2024-06-06 |
Prime Medicine, Inc. |
Modified prime editing guide rnas
|
|
EP4444362A4
(en)
|
2021-12-10 |
2026-04-01 |
Flagship Pioneering Innovations Vi Llc |
CFTR COMPOSITIONS AND MODULATION METHODS
|
|
WO2023192655A2
(en)
|
2022-04-01 |
2023-10-05 |
Prime Medicine, Inc. |
Methods and compositions for editing nucleotide sequences
|